Description

4-[11-[(2,6-Dideoxy-β-D-Ribo-Hexopyranosyl)Oxy]-8,10,12-Trimethyl-1-Oxo-2,4,6,8-Tridecatetrenyl]-2,5-Dihydro-3-Hydroxy-1-Methyl-5-Oxo-1H-Pyrrole-2-Propanoic Acid is a complex, high-purity chemical intermediate characterized by its intricate molecular architecture. This compound is of significant value in advanced pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. It is primarily sought after by R&D laboratories and production facilities in the pharmaceutical and biotechnology sectors for its role as a critical building block in complex organic syntheses.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of specialized active pharmaceutical ingredients (APIs), particularly in antibiotic and antitumor research.
• Biochemical Research: Used as a reference standard or probe in studying biological pathways and enzyme interactions due to its specific structural motifs.
• Organic Synthesis Building Block: Employed in multi-step synthetic routes to construct complex natural product analogs or novel molecular entities.
• Process Development: Serves as a critical material for scaling up and optimizing manufacturing processes for new drug candidates.

Basic Information

Product Name	4-[11-[(2,6-Dideoxy-β-D-Ribo-Hexopyranosyl)Oxy]-8,10,12-Trimethyl-1-Oxo-2,4,6,8-Tridecatetrenyl]-2,5-Dihydro-3-Hydroxy-1-Methyl-5-Oxo-1H-Pyrrole-2-Propanoic Acid
CAS No.	60202-22-4
Molecular Formula	C30H41NO9
Molecular Weight	559.65 g/mol
Synonyms	Doxorubicinone, 14-O-(2,6-Dideoxy-β-D-ribo-hexopyranosyl)-; 14-Hydroxydaunomycinone 14-(2,6-Dideoxy-β-D-ribo-hexopyranoside); Doxorubicin Aglycone; Adriamycinone; (8S,10S)-8-Glycoloyl-10-[(2S,4S,5S,6S)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
EINECS	Contact for details

Quality Control

Our 4-[11-[(2,6-Dideoxy-β-D-Ribo-Hexopyranosyl)Oxy]-8,10,12-Trimethyl-1-Oxo-2,4,6,8-Tridecatetrenyl]-2,5-Dihydro-3-Hydroxy-1-Methyl-5-Oxo-1H-Pyrrole-2-Propanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	Orange to red powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.